What they were paid
AGIOS PHARMACEUTICALS Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $70,000 | $99,968 | $299,689 | $0 | $469,657 |
| FY2023 | $20,962 | $157,474 | $485,247 | $0 | $663,683 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AGIOS PHARMACEUTICALS, INC. DEF 14A filed April 24, 2026, accession 0001193125-26-177086, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025AGIOS PHARMACEUTICALS pays directors a $50,000 cash retainer and $400,000 in Options and RSUs (75% options / 25% RSUs).
Committees
FY2025 · as the proxy prints themAudit
The rest of the AGIOS PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Brian Goff | Director | $0 |
| Catherine Owen Adams | Independent Director | $458,407 |
| Cynthia Smith | Independent Director | $467,157 |
| David Scadden | Independent Director | $469,657 |
| Jacqualyn A. Fouse | Independent Director | $492,157 |
| Jay Backstrom | Independent Director | $657,149 |
| Kaye Foster | Independent Director | $498,407 |
| Maykin Ho | Independent Director | $464,657 |
| Rahul Ballal | Independent Director | $467,157 |
The full AGIOS PHARMACEUTICALS compensation record
free company briefThis page is one director within AGIOS PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat